120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
武汉住院精神分裂症患者便秘相关因素分析
Authors Gong JF, Wu CX, Qiao J, Li LH, Xiang SQ, Liu Y, Zheng HB, Li MC, Xiong ZJ, Wang XJ, Ji QM
Received 2 July 2025
Accepted for publication 16 December 2025
Published 18 January 2026 Volume 2026:19 551062
DOI https://doi.org/10.2147/JMDH.S551062
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Editor who approved publication: Dr David C. Mohr
Ji-Fen Gong,1,2,* Chun-Xi Wu,2,* Juan Qiao,2,* Li-Hua Li,3 Shi-Qiang Xiang,1 Yi Liu,2 Hai-Bo Zheng,2 Ming-Chao Li,4 Zi-Jun Xiong,5 Xiao-Jun Wang,2 Qiu-Ming Ji6
1School of Public Health, Wuhan University of Science and Technology, Wuhan, Hubei, 430075, People’s Republic of China; 2Department of Psychiatry, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China; 3Department of Finance, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China; 4Department of Psychiatry, Wuhan Mental Health Center, Wuhan, Hubei, 430022, People’s Republic of China; 5Department of Laboratory, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China; 6Department of Science, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Shi-Qiang Xiang, School of Public Health, Wuhan University of Science and Technology, 947 Heping Avenue, Qingshan District, Wuhan, Hubei, 430075, People’s Republic of China, Email xiangshiqiang3868@126.com Xiao-Jun Wang, Department of Psychiatry, Wuhan Wudong Hospital, No. 46, Ankang Lane, Wudong Street, Qingshan District, Wuhan, Hubei, 430084, People’s Republic of China, Tel +86 27 5052 8367, Fax +86 27 8643 8247, Email xiaoju.nwang@outlook.com
Objective: To investigate the factors associated with constipation in patients with schizophrenia.
Methods: This retrospective study analysed medical records of hospitalised patients with schizophrenia admitted to a psychiatric department in Wuhan between January and December 2023. Demographic and clinical data were collected and cross-checked by psychiatrists. Logistic regression analysis was used to identify independent risk factors.
Results: Among 904 patients, 268 (29.65%) had constipation, including incomplete intestinal obstruction (5.97%), anal fissures (20.89%) and haemorrhoids (38.10%). The prevalence was higher in women (33.59%) than in men (26.73%). Multivariate logistic regression identified poverty (odds ratio [OR] = 1.60, 95% CI: 1.14– 2.23, P = 0.006), disease duration ≥ 10 years (OR = 4.13, 95% CI: 2.41– 7.07, P < 0.001), clozapine use (OR = 2.56, 95% CI: 1.67– 3.94, P < 0.001), combined drug therapy (OR = 2.58, 95% CI: 1.67– 3.99, P < 0.001), comorbid anxiety disorders (OR = 2.64, 95% CI: 1.79– 3.88, P < 0.001), comorbid hypertension (OR = 3.84, 95% CI: 2.73– 5.39, P < 0.001), dyslipidaemia (OR = 1.81, 95% CI: 1.21– 2.71, P = 0.004) and smoking (OR = 1.57, 95% CI: 1.13– 2.20, P = 0.008) as independent risk factors. Subgroup analyses showed stronger associations between clozapine and constipation in women and between long disease duration and constipation in older patients.
Conclusion: The prevalence of constipation in patients with schizophrenia is high. For high-risk groups with the above factors, early intervention should be implemented to prevent the onset of constipation and improve patients’ quality of life.
Keywords: schizophrenia, constipation, risk factors, psychotropic drugs, anxiety disorders
1School of Public Health, Wuhan University of Science and Technology, Wuhan, Hubei, 430075, People’s Republic of China; 2Department of Psychiatry, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China; 3Department of Finance, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China; 4Department of Psychiatry, Wuhan Mental Health Center, Wuhan, Hubei, 430022, People’s Republic of China; 5Department of Laboratory, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China; 6Department of Science, Wuhan Wudong Hospital, Wuhan, Hubei, 430084, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Shi-Qiang Xiang, School of Public Health, Wuhan University of Science and Technology, 947 Heping Avenue, Qingshan District, Wuhan, Hubei, 430075, People’s Republic of China, Email xiangshiqiang3868@126.com Xiao-Jun Wang, Department of Psychiatry, Wuhan Wudong Hospital, No. 46, Ankang Lane, Wudong Street, Qingshan District, Wuhan, Hubei, 430084, People’s Republic of China, Tel +86 27 5052 8367, Fax +86 27 8643 8247, Email xiaoju.nwang@outlook.com
Objective: To investigate the factors associated with constipation in patients with schizophrenia.
Methods: This retrospective study analysed medical records of hospitalised patients with schizophrenia admitted to a psychiatric department in Wuhan between January and December 2023. Demographic and clinical data were collected and cross-checked by psychiatrists. Logistic regression analysis was used to identify independent risk factors.
Results: Among 904 patients, 268 (29.65%) had constipation, including incomplete intestinal obstruction (5.97%), anal fissures (20.89%) and haemorrhoids (38.10%). The prevalence was higher in women (33.59%) than in men (26.73%). Multivariate logistic regression identified poverty (odds ratio [OR] = 1.60, 95% CI: 1.14– 2.23, P = 0.006), disease duration ≥ 10 years (OR = 4.13, 95% CI: 2.41– 7.07, P < 0.001), clozapine use (OR = 2.56, 95% CI: 1.67– 3.94, P < 0.001), combined drug therapy (OR = 2.58, 95% CI: 1.67– 3.99, P < 0.001), comorbid anxiety disorders (OR = 2.64, 95% CI: 1.79– 3.88, P < 0.001), comorbid hypertension (OR = 3.84, 95% CI: 2.73– 5.39, P < 0.001), dyslipidaemia (OR = 1.81, 95% CI: 1.21– 2.71, P = 0.004) and smoking (OR = 1.57, 95% CI: 1.13– 2.20, P = 0.008) as independent risk factors. Subgroup analyses showed stronger associations between clozapine and constipation in women and between long disease duration and constipation in older patients.
Conclusion: The prevalence of constipation in patients with schizophrenia is high. For high-risk groups with the above factors, early intervention should be implemented to prevent the onset of constipation and improve patients’ quality of life.
Keywords: schizophrenia, constipation, risk factors, psychotropic drugs, anxiety disorders